Hypertensive disease
|
0.030 |
AlteredExpression
|
group |
BEFREE |
Increased CLIC4 expression is an early manifestation and mediator of endothelial dysfunction in pulmonary hypertension.
|
24503951 |
2014 |
Neurodegenerative Disorders
|
0.020 |
Biomarker
|
group |
BEFREE |
Role of c-Myc/chloride intracellular channel 4 pathway in lipopolysaccharide-induced neurodegenerative diseases.
|
31693917 |
2020 |
Endothelial dysfunction
|
0.020 |
AlteredExpression
|
phenotype |
BEFREE |
Increased expression of CLIC4 (chloride intracellular channel 4) is a feature of endothelial dysfunction in pulmonary arterial hypertension, but its role in disease pathology is not fully understood.
|
30582444 |
2019 |
Pulmonary arterial hypertension
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
Increased expression of CLIC4 (chloride intracellular channel 4) is a feature of endothelial dysfunction in pulmonary arterial hypertension, but its role in disease pathology is not fully understood.
|
30582444 |
2019 |
Idiopathic pulmonary arterial hypertension
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
Increased expression of CLIC4 (chloride intracellular channel 4) is a feature of endothelial dysfunction in pulmonary arterial hypertension, but its role in disease pathology is not fully understood.
|
30582444 |
2019 |
Neurodegenerative Disorders
|
0.020 |
Biomarker
|
group |
BEFREE |
Targeting CLIC4 in neurons may therefore provide a therapeutic approach for managing progressive neurodegenerative diseases that arise from neuronal apoptosis.
|
30237421 |
2018 |
Carcinoma, Ovarian Epithelial
|
0.020 |
Biomarker
|
disease |
BEFREE |
These results suggest CLIC1 and CLIC4 are promising serum and tissue biomarkers as well as potential therapeutic targets for all EOC subtypes.
|
30282979 |
2018 |
Endothelial dysfunction
|
0.020 |
AlteredExpression
|
phenotype |
BEFREE |
Increased CLIC4 expression is an early manifestation and mediator of endothelial dysfunction in pulmonary hypertension.
|
24503951 |
2014 |
Pulmonary arterial hypertension
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
Aberrant CLIC4 expression may contribute to the vascular pathology of pulmonary arterial hypertension.
|
24503951 |
2014 |
Idiopathic pulmonary arterial hypertension
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
Similarly, inhibition of CLIC4 expression in blood-derived endothelial cells from patients with idiopathic pulmonary arterial hypertension attenuated the abnormal angiogenic behavior that characterizes these cells.
|
24503951 |
2014 |
Carcinoma, Ovarian Epithelial
|
0.020 |
Biomarker
|
disease |
BEFREE |
Molecular targeting of ROS and CLIC4 has the potential to develop novel therapies for ovarian cancer.
|
19781102 |
2009 |
Arteriosclerosis
|
0.010 |
Biomarker
|
disease |
BEFREE |
We revealed for the first time that miR-217-5p inhibited apoptosis of endothelial cells in atherosclerosis and identified CLIC4 as a novel target of miR-217-5p.
|
31744714 |
2020 |
Atherosclerosis
|
0.010 |
Biomarker
|
disease |
BEFREE |
We revealed for the first time that miR-217-5p inhibited apoptosis of endothelial cells in atherosclerosis and identified CLIC4 as a novel target of miR-217-5p.
|
31744714 |
2020 |
Adenocarcinoma
|
0.010 |
AlteredExpression
|
group |
BEFREE |
We analyzed the expression of CLIC4 in 102 pairs of gastric adenocarcinomas by Western blot and RT-PCR.
|
31560739 |
2019 |
Malignant neoplasm of stomach
|
0.010 |
Biomarker
|
disease |
BEFREE |
Moreover, anchorage-independent growth of GC cells was decreased and the cells became more sensitive to 5-fluorouracil and etoposide treatment when CLIC4 was overexpressed.
|
31560739 |
2019 |
Stomach Carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Moreover, anchorage-independent growth of GC cells was decreased and the cells became more sensitive to 5-fluorouracil and etoposide treatment when CLIC4 was overexpressed.
|
31560739 |
2019 |
Merkel cell carcinoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Consistent with these data, we confirmed that CLIC1 and CLIC4 are up-regulated in primary MCPyV-positive MCC patient samples.
|
29462791 |
2018 |
Nephrosclerosis
|
0.010 |
Biomarker
|
disease |
BEFREE |
One specific protein, chloride intracellular channel 4 (CLIC4), not implicated so far in the development of hypertension and nephrosclerosis, was further studied by Western blotting, immunohistochemistry and immunofluorescence.
|
29131056 |
2018 |
Benign Neoplasm
|
0.010 |
Biomarker
|
group |
BEFREE |
CLIC4 also stained benign tumors but staining was limited to nuclei; whereas malignant tumors showed diffuse cellular staining of stromal and tumor cells.
|
30282979 |
2018 |
Tumor Progression
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
Elevated CLIC4 expression, but not CLIC1 expression, was a negative indicator of patient survival, and CLIC4 knockdown in cultured cells decreased cell proliferation and migration indicating a potential role in tumor progression.
|
30282979 |
2018 |
Adult Liver Carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
SiRNA-Mediated Down-Regulation of CLIC4 Gene Inhibits Cell Proliferation and Accelerates Cell Apoptosis of Mouse Liver Cancer Hca-F and Hca-P Cells.
|
28636115 |
2018 |
Liver and Intrahepatic Biliary Tract Carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
SiRNA-Mediated Down-Regulation of CLIC4 Gene Inhibits Cell Proliferation and Accelerates Cell Apoptosis of Mouse Liver Cancer Hca-F and Hca-P Cells.
|
28636115 |
2018 |
Malignant neoplasm of liver
|
0.010 |
Biomarker
|
disease |
BEFREE |
SiRNA-Mediated Down-Regulation of CLIC4 Gene Inhibits Cell Proliferation and Accelerates Cell Apoptosis of Mouse Liver Cancer Hca-F and Hca-P Cells.
|
28636115 |
2018 |
Epithelial ovarian cancer
|
0.010 |
Biomarker
|
disease |
BEFREE |
These results suggest CLIC1 and CLIC4 are promising serum and tissue biomarkers as well as potential therapeutic targets for all EOC subtypes.
|
30282979 |
2018 |
Myeloid Leukemia
|
0.010 |
Biomarker
|
disease |
BEFREE |
Our results showed that the augmented cytotoxic effect of combination treatment only occurs in SNU398 and SNU387, and not in HepG2 and Huh-1 (ASS(+)) cells, and is partly due to reduced anti-apoptotic proteins X-linked inhibitor of apoptosis protein (XIAP), myeloid leukemia cell differentiation protein (Mcl-1) and B-cell lymphoma-2 (Bcl-2).
|
28587170 |
2017 |